ID Q8DQB5_STRR6 Unreviewed; 647 AA. AC Q8DQB5; DT 01-MAR-2003, integrated into UniProtKB/TrEMBL. DT 01-MAR-2003, sequence version 1. DT 27-MAR-2024, entry version 150. DE RecName: Full=DNA topoisomerase 4 subunit B {ECO:0000256|HAMAP-Rule:MF_00939}; DE EC=5.6.2.2 {ECO:0000256|HAMAP-Rule:MF_00939}; DE AltName: Full=Topoisomerase IV subunit B {ECO:0000256|HAMAP-Rule:MF_00939}; GN Name=parE {ECO:0000256|HAMAP-Rule:MF_00939, GN ECO:0000313|EMBL:AAK99560.1}; GN OrderedLocusNames=spr0756 {ECO:0000313|EMBL:AAK99560.1}; OS Streptococcus pneumoniae (strain ATCC BAA-255 / R6). OC Bacteria; Bacillota; Bacilli; Lactobacillales; Streptococcaceae; OC Streptococcus. OX NCBI_TaxID=171101 {ECO:0000313|EMBL:AAK99560.1, ECO:0000313|Proteomes:UP000000586}; RN [1] {ECO:0000313|EMBL:AAK99560.1, ECO:0000313|Proteomes:UP000000586} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC BAA-255 / R6 {ECO:0000313|Proteomes:UP000000586}; RX PubMed=11544234; DOI=10.1128/JB.183.19.5709-5717.2001; RA Hoskins J.A., Alborn W.Jr., Arnold J., Blaszczak L., Burgett S., RA DeHoff B.S., Estrem S., Fritz L., Fu D.-J., Fuller W., Geringer C., RA Gilmour R., Glass J.S., Khoja H., Kraft A., LaGace R., LeBlanc D.J., RA Lee L.N., Lefkowitz E.J., Lu J., Matsushima P., McAhren S., McHenney M., RA McLeaster K., Mundy C., Nicas T.I., Norris F.H., O'Gara M., Peery R., RA Robertson G.T., Rockey P., Sun P.-M., Winkler M.E., Yang Y., RA Young-Bellido M., Zhao G., Zook C., Baltz R.H., Jaskunas S.Richard., RA Rosteck P.R.Jr., Skatrud P.L., Glass J.I.; RT "Genome of the bacterium Streptococcus pneumoniae strain R6."; RL J. Bacteriol. 183:5709-5717(2001). RN [2] {ECO:0007829|PDB:4LP0, ECO:0007829|PDB:4LPB} RP X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-226. RX PubMed=24098982; DOI=10.1021/jm401208b; RA Basarab G.S., Manchester J.I., Bist S., Boriack-Sjodin P.A., Dangel B., RA Illingworth R., Sherer B.A., Sriram S., Uria-Nickelsen M., Eakin A.E.; RT "Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP RT competitive dual targeting type II topoisomerase inhibiting antibacterial RT agents."; RL J. Med. Chem. 56:8712-8735(2013). RN [3] {ECO:0007829|PDB:4MOT} RP X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-226. RX PubMed=24405701; DOI=10.1016/j.bmcl.2013.12.080; RA Kale R.R., Kale M.G., Waterson D., Raichurkar A., Hameed S.P., RA Manjunatha M.R., Kishore Reddy B.K., Malolanarasimhan K., Shinde V., RA Koushik K., Jena L.K., Menasinakai S., Humnabadkar V., Madhavapeddi P., RA Basavarajappa H., Sharma S., Nandishaiah R., Mahesh Kumar K.N., Ganguly S., RA Ahuja V., Gaonkar S., Naveen Kumar C.N., Ogg D., Boriack-Sjodin P.A., RA Sambandamurthy V.K., de Sousa S.M., Ghorpade S.R.; RT "Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of RT antitubercular activity and efficacy."; RL Bioorg. Med. Chem. Lett. 24:870-879(2014). RN [4] {ECO:0007829|PDB:5BOC} RP X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1-226. RA Chen G.Y., Ng F.M., Tan Y.W., Poulsen A., Seetoh W., Lin G., Kang C., RA Then S.W., Ahmad N.H., Wong Y.L., Ng H., Chia B.C.S., Lau Q.Y., Hill J., RA Hung A.W., Keller T.H.; RT "Application of Fragment-based Drug Discovery against DNA GyraseB."; RL Submitted (MAY-2015) to the PDB data bank. RN [5] {ECO:0007829|PDB:5BOD} RP X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1-226. RA Chen G.Y., Ng F.M., Tan Y.W., Poulsen A., Seetoh W., Lin G., Kang C., RA Then S.W., Ahmad N.H., Wong Y.L., Ng H.Q., Chia B.C.S., Lau Q.Y., Hill J., RA Hung A.W., Keller T.H.; RT "Application of Fragment-based Drug Discovery against DNA GyraseB."; RL Submitted (MAY-2015) to the PDB data bank. CC -!- FUNCTION: Topoisomerase IV is essential for chromosome segregation. It CC relaxes supercoiled DNA. Performs the decatenation events required CC during the replication of a circular DNA molecule. {ECO:0000256|HAMAP- CC Rule:MF_00939}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP-dependent breakage, passage and rejoining of double- CC stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000256|ARBA:ARBA00000185, CC ECO:0000256|HAMAP-Rule:MF_00939}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000256|ARBA:ARBA00001946}; CC -!- SUBUNIT: Heterotetramer composed of ParC and ParE. {ECO:0000256|HAMAP- CC Rule:MF_00939}. CC -!- SIMILARITY: Belongs to the type II topoisomerase family. ParE type 2 CC subfamily. {ECO:0000256|HAMAP-Rule:MF_00939}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AE007317; AAK99560.1; -; Genomic_DNA. DR PIR; D97966; D97966. DR RefSeq; NP_358350.1; NC_003098.1. DR RefSeq; WP_000037270.1; NC_003098.1. DR PDB; 4LP0; X-ray; 1.95 A; A=1-226. DR PDB; 4LPB; X-ray; 1.75 A; A=1-226. DR PDB; 4MOT; X-ray; 1.75 A; A=1-226. DR PDB; 5BOC; X-ray; 2.20 A; A=1-226. DR PDB; 5BOD; X-ray; 2.20 A; A=1-226. DR PDBsum; 4LP0; -. DR PDBsum; 4LPB; -. DR PDBsum; 4MOT; -. DR PDBsum; 5BOC; -. DR PDBsum; 5BOD; -. DR AlphaFoldDB; Q8DQB5; -. DR SMR; Q8DQB5; -. DR STRING; 171101.spr0756; -. DR KEGG; spr:spr0756; -. DR PATRIC; fig|171101.6.peg.836; -. DR eggNOG; COG0187; Bacteria. DR HOGENOM; CLU_006146_1_2_9; -. DR Proteomes; UP000000586; Chromosome. DR GO; GO:0005694; C:chromosome; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule. DR GO; GO:0003918; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; IEA:UniProtKB-UniRule. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-UniRule. DR GO; GO:0006265; P:DNA topological change; IEA:UniProtKB-UniRule. DR CDD; cd16928; HATPase_GyrB-like; 1. DR CDD; cd00822; TopoII_Trans_DNA_gyrase; 1. DR Gene3D; 3.30.230.10; -; 1. DR Gene3D; 3.40.50.670; -; 1. DR Gene3D; 3.30.565.10; Histidine kinase-like ATPase, C-terminal domain; 1. DR HAMAP; MF_00939; ParE_type2; 1. DR InterPro; IPR002288; DNA_gyrase_B_C. DR InterPro; IPR003594; HATPase_C. DR InterPro; IPR036890; HATPase_C_sf. DR InterPro; IPR005740; ParE_type2. DR InterPro; IPR020568; Ribosomal_Su5_D2-typ_SF. DR InterPro; IPR014721; Ribsml_uS5_D2-typ_fold_subgr. DR InterPro; IPR001241; Topo_IIA. DR InterPro; IPR013760; Topo_IIA-like_dom_sf. DR InterPro; IPR000565; Topo_IIA_B. DR InterPro; IPR013759; Topo_IIA_B_C. DR InterPro; IPR013506; Topo_IIA_bsu_dom2. DR InterPro; IPR018522; TopoIIA_CS. DR InterPro; IPR006171; TOPRIM_domain. DR NCBIfam; TIGR01058; parE_Gpos; 1. DR PANTHER; PTHR45866; DNA GYRASE/TOPOISOMERASE SUBUNIT B; 1. DR PANTHER; PTHR45866:SF12; DNA TOPOISOMERASE 4 SUBUNIT B; 1. DR Pfam; PF00204; DNA_gyraseB; 1. DR Pfam; PF00986; DNA_gyraseB_C; 1. DR Pfam; PF02518; HATPase_c; 1. DR Pfam; PF01751; Toprim; 1. DR PRINTS; PR01159; DNAGYRASEB. DR PRINTS; PR00418; TPI2FAMILY. DR SMART; SM00387; HATPase_c; 1. DR SMART; SM00433; TOP2c; 1. DR SUPFAM; SSF55874; ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase; 1. DR SUPFAM; SSF54211; Ribosomal protein S5 domain 2-like; 1. DR SUPFAM; SSF56719; Type II DNA topoisomerase; 1. DR PROSITE; PS00177; TOPOISOMERASE_II; 1. DR PROSITE; PS50880; TOPRIM; 1. PE 1: Evidence at protein level; KW 3D-structure {ECO:0007829|PDB:4LP0, ECO:0007829|PDB:4LPB}; KW ATP-binding {ECO:0000256|HAMAP-Rule:MF_00939}; KW DNA-binding {ECO:0000256|ARBA:ARBA00023125, ECO:0000256|HAMAP- KW Rule:MF_00939}; KW Isomerase {ECO:0000256|ARBA:ARBA00023235, ECO:0000256|HAMAP-Rule:MF_00939}; KW Magnesium {ECO:0000256|ARBA:ARBA00022842}; KW Metal-binding {ECO:0000256|ARBA:ARBA00022723}; KW Nucleotide-binding {ECO:0000256|HAMAP-Rule:MF_00939}; KW Reference proteome {ECO:0000313|Proteomes:UP000000586}; KW Topoisomerase {ECO:0000256|HAMAP-Rule:MF_00939}. FT DOMAIN 427..541 FT /note="Toprim" FT /evidence="ECO:0000259|PROSITE:PS50880" FT REGION 391..421 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 391..411 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 11 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" FT BINDING 51 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" FT BINDING 78 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" FT BINDING 118..124 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" FT BINDING 344 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" FT SITE 461 FT /note="Interaction with DNA" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" FT SITE 513 FT /note="Interaction with DNA" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" FT SITE 629 FT /note="Interaction with DNA" FT /evidence="ECO:0000256|HAMAP-Rule:MF_00939" SQ SEQUENCE 647 AA; 71665 MW; 0AF7382C72772713 CRC64; MSKKEININN YNDDAIQVLE GLDAVRKRPG MYIGSTDGAG LHHLVWEIVD NAVDEALSGF GDRIDVTINK DGSLTVQDHG RGMPTGMHAM GIPTVEVIFT ILHAGGKFGQ GGYKTSGGLH GVGSSVVNAL SSWLEVEITR DGAVYKQRFE NGGKPVTTLK KIGTALKSKT GTKVTFMPDA TIFSTTDFKY NTISERLNES AFLLKNVTLS LTDKRTDEAI EFHYENGVQD FVSYLNEDKE ILTPVLYFEG EDNGFQVEVA LQYNDGFSDN ILSFVNNVRT KDGGTHETGL KSAITKVMND YARKTGLLKE KDKNLEGSDY REGLAAVLSI LVPEEHLQFE GQTKDKLGSP LARPVVDGIV ADKLTFFLME NGELASNLIR KAIKARDARE AARKARDESR NGKKNKKDKG LLSGKLTPAQ SKNPAKNELY LVEGDSAGGS AKQGRDRKFQ AILPLRGKVI NTAKAKMADI LKNEEINTMI YTIGAGVGAD FSIEDANYDK IIIMTDADTD GAHIQTLLLT FFYRYMRPLV EAGHVYIALP PLYKMSKGKG KKEEVAYAWT DGELEELRKQ FGKGATLQRY KGLGEMNADQ LWETTMNPET RTLIRVTIED LARAERRVNV LMGDKVEPRR KWIEDNVKFT LEEATVF //